Elise M. Cribbin

Elise M. Cribbin

Auto-generated profile, based on publicly available information

Elise M. Cribbin

School of Biomedical Engineering, University of Technology 4 Sydney, New South Wales 2007, Australia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2022 in Biomicrofluidics
Verified
Journal Article
Closed access
PDF file
ZYZhenxu Yang
Zhenxu Yang
XLXiaochen Liu
Xiaochen Liu
ECElise M. Cribbin
Elise M. Cribbin
AKAlice M. Kim
Alice M. Kim
Jiao Jiao LiJiao Jiao Li
Jiao Jiao Li
KYKen-Tye Yong
Ken-Tye Yong
The liver is the largest internal organ in the human body with largest mass of glandular tissue. Modeling the liver has been challenging due to its variety of major functions, including processing nutrients and vitamins, detoxification, and regulating body metabolism. The intrinsic shortfalls of conventional two-dimensional (2D) cell culture methods for studying pharmacokinetics in parenchymal cells (hepatocytes) have contributed to suboptimal outcomes in clinical trials and drug development. This prompts the development of highly automated, biomimetic liver-on-a-chip (LOC) devices to simulate native liver structure and function, with the aid of recent progress in microfluidics. LOC offers a cost-effective and accurate model for pharmacokinetics, pharmacodynamics, and toxicity studies. This review provides a critical update on recent developments in designing LOCs and fabrication strategies. We highlight biomimetic design approaches for LOCs, including mimicking liver structure and function, and their diverse applications in areas such as drug screening, toxicity assessment, and real-time biosensing. We capture the newest ideas in the field to advance the field of LOCs and address current challenges.